The Notch pathway: a crossroad between the life and death of the endothelium
The Notch pathway: a crossroad between the life and death of the endothelium
复制标题
DOI:
10.1093/eurheartj/ehs141
复制
发表时间:
2013-08-01
影响因子:
39.3
通讯作者:
Ferrari, Roberto
中科院分区:
文献类型:
--
作者:
Rizzo, Paola;Miele, Lucio;Ferrari, Roberto
The endothelium is attracting increasing attention from oncologists and cardiologists. Inhibition of angiogenesis in tumours by the induction of endothelial injury is considered a promising therapeutic approach. Conversely, endothelial injury is implicated in atherosclerosis, thrombosis, hypertension, and diabetes. Endothelial death occurs by apoptosis and the regenerative capacity of mature endothelial cells is limited: wherever an imbalance between death and regeneration of the endothelium occurs, its integrity and function is threatened and the origin and progression of cardiovascular disease is favoured. Notch signalling is involved in the cell fate decision and, directly or by cross-talking with other pathways, has been shown to regulate apoptosis, regeneration, proliferation, and migration of endothelial cells. 1, 2 Inhibition of the Notch pathways is useful in oncology to repress angiogenesis in tumours 3, 4 but its manipulation could be useful in cardiology to reduce endothelial apoptosis and to favour angiogenesis.